| Website | poscobioventures.... |
| Phone | (760) 448-2848 |
| jgoag@poscobioven... | |
| Employees | |
| Founded | 1/02 |
POSCO BioVentures’ primary investment focus is on companies with novel, proprietary bio-molecules. POSCO BioVentures expects that 70% of its investments will be in companies focused on novel proprietary bio-molecules, with the balance of the investments in other enabling technologies.
| Company | Date | Round | Size | Participants |
| TransMedics | 3/10 | Series E | $36M | 11 |
| Pulmonx | 3/10 | Series C | $32M | 7 |
| Accera | 11/08 | Series C | $35M | 2 |
| TransMedics | 4/07 | Series D | $25.5M | 9 |
| ProteinSimple | 1/06 | Series B | $27M | 8 |
| Accera | 6/04 | Series A | $3.05M | 1 |
| TransMedics | 1/04 | Series B | $27.6M | 8 |
